‘Cream of the Crop’ – Manuka Honey’s Powerful Therapeutic Benefits and Promising Market Prospects

Summary

Manuka honey is a unique honey derived from the nectar of the manuka tea tree, which grows mainly in remote, pristine native forests of New Zealand and Australia. The leaves and bark of the tree have been used by Māori as a natural remedy with analgesic, antipyretic, and antiseptic properties. Compared with regular honey, manuka honey contains phenol and has stable antibacterial activity that is not easily broken down by the body.

It effectively improves gastrointestinal disorders (such as gastroenteritis, indigestion, diarrhoea, duodenal ulcers) and skin wounds. Its therapeutic benefits have been clinically proven in New Zealand and Australia, and it is the only honey ingredient approved for the pharmaceutical market in the United States. Known as the ‘cream of the crop’, manuka honey has broad market prospects.

Key companies include New Zealand-based Comvita, Manuka Health, Arataki Honey, Watson & Son, Streamland, and Pure Honey New Zealand.

Commentary

As an iconic New Zealand product, manuka honey’s unique antibacterial and therapeutic properties have gained global recognition, particularly with its pharmaceutical approval in the US market, opening the door to high-end medical applications for New Zealand’s honey industry. For local small and medium-sized enterprises (SMEs), this represents significant commercial opportunities: on one hand, they can leverage manuka honey’s ‘superfood’ positioning to expand into the health supplement and functional food markets; on the other, with rising global demand for natural antibacterial products, applications in skincare and oral care are worth exploring. However, competition is intensifying, with Australia also promoting its manuka honey, and emerging markets like China imposing strict requirements on honey quality and traceability.

SMEs need to focus on brand building, quality certification (e.g., UMF rating), and supply chain transparency to build consumer trust. Additionally, US-China trade tensions may affect Chinese consumers’ purchasing power for imported honey, but the upgraded free trade agreement between New Zealand and China has lowered tariffs, facilitating exports. Businesses are advised to target Chinese e-commerce platforms and health food channels, while developing differentiated products such as manuka honey capsules or medical-grade dressings to enhance value.

Overall, the market outlook for manuka honey is positive, but success hinges on quality control and targeted marketing.

Keywords: Manuka honey, New Zealand, antibacterial, therapeutic benefits, market prospects, Comvita, Manuka Health, UMF, export, health supplements

Source: NetEase